The healthiness of appetite suppressants depends on various factors, including specific medication, individual health conditions, and proper usage
These medications contain both a GLP-1 receptor agonist and GIP-1 (gastric inhibitory peptide) agonist
Using a 90-degree angle, pinching the skin, and using the right needle length reduces this risk significantly
Zepbound Data as Reported by Lilly The manufacturers language on the weight loss indication reads thus: Zepbound is indicated in combination with a reduced-calorie diet and increased physical activity: to reduce excess body weight and maintain weight reduction long term in adults with obesity or adults with overweight in the presence of at least one weight-related comorbid condition. At 72 weeks, patients taking Zepbound 15mg lost an average of 20.9% of their body weight
The semaglutide versus tirzepatide comparison provides context for understanding how these two GLP-1 agents differ mechanistically
Focus instead on nutrition that keeps you comfortable and energized, which sets a positive tone for your ongoing treatment journey